These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 16199631)

  • 21. Maternal serum alpha-fetoprotein screening: promise not yet fulfilled.
    Nadler HL; Simpson JL
    Am J Obstet Gynecol; 1979 Sep; 135(1):1-2. PubMed ID: 89812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results and benefits of a maternal serum alpha-fetoprotein screening program.
    Milunsky A; Alpert E
    JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Contribution of amniocentesis to prenatal screening of neural tube closing defects: evaluation of 10 years of a center's experience].
    Guibaud S; Capella-Bonnet M; Simplot A
    J Genet Hum; 1985 Sep; 33(3-4):339-45. PubMed ID: 2414399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center.
    Cariati E; Brizzi L; Periti E
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):72-6. PubMed ID: 2480428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal diagnosis policy without routine amniocentesis in pregnancies with a positive family history for neural tube defects.
    Papp Z; Tóth Z; Török O; Szabó M
    Am J Med Genet; 1987 Jan; 26(1):103-10. PubMed ID: 2433941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of prenatal diagnosis on NTD surveillance.
    Allen WP; Stevenson RE; Thompson SJ; Dean JH
    Prenat Diagn; 1996 Jun; 16(6):531-5. PubMed ID: 8809894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of prenatal mid-trimester screening on the prevalence of fetal structural anomalies: a prospective epidemiological study.
    Papp Z; Tóth-Pál E; Papp C; Tóth Z; Szabó M; Veress L; Török O
    Ultrasound Obstet Gynecol; 1995 Nov; 6(5):320-6. PubMed ID: 8590201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Maternal Serum Alpha-Fetoprotein and Ultrasonography in Contemporary Detection of Spina Bifida.
    Racusin DA; Villarreal S; Antony KM; Harris RA; Mastrobattista J; Lee W; Shamshirsaz AA; Belfort M; Aagaard KM
    Am J Perinatol; 2015 Dec; 32(14):1287-91. PubMed ID: 26332586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
    Milunsky A; Alpert E; Neff RK; Frigoletto FD
    Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. alpha-Fetoprotein screening.
    Burton BK
    Adv Pediatr; 1986; 33():181-96. PubMed ID: 2432763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-fetoprotein.
    Drugan A; Dvorin E; Obrien JE; Johnson MP; Evans MI
    Curr Opin Obstet Gynecol; 1991 Apr; 3(2):230-4. PubMed ID: 1717020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neural tube defects in the sample of genetic counselling.
    Joó JG; Beke A; Papp C; Tóth-Pál E; Csaba A; Szigeti Z; Papp Z
    Prenat Diagn; 2007 Oct; 27(10):912-21. PubMed ID: 17602445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.
    Brizzi L; Cariati E; Periti E; Nannini R; Torricelli F; Cappelli G; Gheri G
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):85-8. PubMed ID: 2480431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.
    Milunsky A; Alpert E; Kitzmiller JL; Younger MD; Neff RK
    Am J Obstet Gynecol; 1982 Apr; 142(8):1030-2. PubMed ID: 6176126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serum screening of pregnant women for fetal neural tube defects and Down syndrome; initial experiences in The Netherlands].
    Beekhuis JR; Mantingh A; de Wolf BT; van Lith JM; Breed AS
    Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1303-7. PubMed ID: 7688448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of abnormal second trimester maternal serum alpha-fetoprotein (MSAFP) levels and adverse pregnancy outcome.
    Kiran TS; Bethel J; Bhal PS
    J Obstet Gynaecol; 2005 Apr; 25(3):253-6. PubMed ID: 16147728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical studies on maternal serum alpha-fetoprotein (MSAFP) of 532 cases--the median value, pregnancy outcomes and clinical evaluation].
    Hayashi M; Kohzu H
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1211-8. PubMed ID: 1385554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
    Hu YL;
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extremely high maternal serum alpha-fetoprotein levels at second-trimester screening.
    Killam WP; Miller RC; Seeds JW
    Obstet Gynecol; 1991 Aug; 78(2):257-61. PubMed ID: 1712441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of elevated maternal serum alpha-fetoprotein (MSAFP) and low estriol is highly predictive of anencephaly.
    Yaron Y; Hamby DD; O'Brien JE; Critchfield G; Leon J; Ayoub M; Johnson MP; Evans MI
    Am J Med Genet; 1998 Jan; 75(3):297-9. PubMed ID: 9475601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.